Behaviour change, weight loss and remission of Type 2 diabetes: a community‐based prospective cohort study

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial

(2019) Michael E J Lean et al.   Lancet Diabetes & Endocrinology

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial

(2018) Michael EJ Lean et al.   LANCET

Beating type 2 diabetes into remission

(2017) Louise McCombie et al.   BMJ-British Medical Journal

Beating type 2 diabetes into remission

(2017) Louise McCombie et al.   BMJ-British Medical Journal

Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders

(2016) Sarah Steven et al.   DIABETES CARE

Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes

(2012) Edward W. Gregg et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial

(2012) Rebecca K Simmons et al.   LANCET

Protocol for the ADDITION-Plus study: a randomised controlled trial of an individually-tailored behaviour change intervention among people with recently diagnosed type 2 diabetes under intensive UK general practice care

(2011) Simon J Griffin et al.   BMC PUBLIC HEALTH

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

(2011) Simon J Griffin et al.   LANCET

The ADDITION-Cambridge trial protocol: a cluster – randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients

(2009) Justin B Echouffo-Tcheugui et al.   BMC PUBLIC HEALTH

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

(2008) Anne Katrin Sjølie et al.   LANCET